期刊文献+
共找到41篇文章
< 1 2 3 >
每页显示 20 50 100
人脑髓鞘碱性蛋白对H_2O_2诱导人肺癌细胞YTLMC-90凋亡的抑制作用 被引量:9
1
作者 陈建业 王晓明 +5 位作者 刘戟 陈璟歆 王若菡 彭文珍 程汉华 陈俊杰 《癌症》 SCIE CAS CSCD 北大核心 2006年第2期170-174,共5页
背景与目的:人脑髓鞘碱性蛋白(myelinbasicprotein,MBP)广泛分布于神经系统及多种非神经组织之中,而且在肺癌、乳腺癌、神经胶质瘤等多种肿瘤细胞中均检查到MBP的表达。但MBP与癌细胞侵犯神经组织的活性是否相关、与肺癌细胞的生物学行... 背景与目的:人脑髓鞘碱性蛋白(myelinbasicprotein,MBP)广泛分布于神经系统及多种非神经组织之中,而且在肺癌、乳腺癌、神经胶质瘤等多种肿瘤细胞中均检查到MBP的表达。但MBP与癌细胞侵犯神经组织的活性是否相关、与肺癌细胞的生物学行为是否相关尚未见报道。本研究主要探讨MBP对过氧化氢(H2O2)诱导人肺癌细胞YTLMC-90凋亡的影响。方法:实验分为MBPcDNA微基因pSVCEPMBPCAT转染组(试验组)、空质粒pSVCEPCAT转染组和未转染组(对照组)。将含人Ⅰ型胶原a1链(COLⅠA1)基因启动子和增强子元件、并在其3′端接MBPcDNA的微基因,转染YTLMC-90细胞,并驱动MBP异位表达;采用MTT法检测细胞增殖,吖啶橙荧光染色显微镜和电镜观察细胞形态及其超微结构的改变;琼脂糖凝胶电泳检测染色质DNA断裂。结果:200μmol/LH2O2作用24h后,转染组、未转染组和空载体pSVCEPCAT转染组YTLMC-90细胞的生长抑制率分别为36.67%、84.00%和78.67%(P<0.001);对照组YTLMC-90细胞普遍可见凋亡细胞特有的形态学及生物化学改变,如胞核固缩、染色质断裂,DNA电泳呈梯状条带;而MBPcDNA微基因转染的YTLMC-90细胞未发现上述凋亡特征。结论:MBP促进YTLMC-90细胞增殖和拮抗H2O2诱导的凋亡,明显减少H2O2对YTLMC-90的细胞毒作用。 展开更多
关键词 髓鞘碱性蛋白 微基因 过氧化氢 肺肿瘤 YTLMC-90细胞系 凋亡
下载PDF
Comprehensive genetic diagnosis of patients with Duchenne/Becker muscular dystrophy(DMD/BMD) and pathogenicity analysis of splice site variants in the DMD gene 被引量:4
2
作者 Yan-mei YANG Kai YAN +7 位作者 Bei LIU Min CHEN Li-ya WANG Ying-zhi HUANG Ye-qing QIAN Yi-xi SUN Hong-ge LI Min-yue DONG 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2019年第9期753-771,共19页
Duchenne muscular dystrophy(DMD)and Becker muscular dystrophy(BMD)are caused by mutations in the DMD gene.The aim of this study is to identify pathogenic DMD variants in probands and reduce the risk of recurrence of t... Duchenne muscular dystrophy(DMD)and Becker muscular dystrophy(BMD)are caused by mutations in the DMD gene.The aim of this study is to identify pathogenic DMD variants in probands and reduce the risk of recurrence of the disease in affected families.Variations in 100 unrelated DMD/BMD patients were detected by multiplex ligation-dependent probe amplification(MLPA)and next-generation sequencing(NGS).Pathogenic variants in DMD were successfully identified in all cases,and 11 of them were novel.The most common mutations were intragenic deletions(69%),with two hotspots located in the 5'end(exons 2–19)and the central of the DMD gene(exons 45–55),while point mutations were observed in 22%patients.Further,c.1149+1G>A and c.1150?2A>G were confirmed by hybrid minigene splicing assay(HMSA).This two splice site mutations would lead to two aberrant DMD isoforms which give rise to severely truncated protein.Therefore,the clinical use of MLPA,NGS,and HMSA is an effective strategy to identify variants.Importantly,eight embryos were terminated pregnancies according to prenatal diagnosis and a healthy boy was successfully delivered by preimplantation genetic diagnosis(PGD).Early and accurate genetic diagnosis is essential for prenatal diagnosis/PGD to reduce the risk of recurrence of DMD in affected families. 展开更多
关键词 Dystrophin gene VARIATION Genetic diagnosis Splice site mutation Hybrid minigene splicing assay
原文传递
人组织型纤溶酶原激活剂突变体微小基因的构建 被引量:3
3
作者 谭晓红 周江 +3 位作者 陈红星 邓继先 杨晓 黄培堂 《生物技术通讯》 CAS 2001年第1期9-11,共3页
tPA基因全长约 36kb ,至少由 13个内含子分隔为 14个外显子。根据tPA的第一、二外显子的编码情况 ,考虑建立从第二至第六外显子序列在内的tPA微小基因。
关键词 组织型纤维酶原激活剂 测序 微小基因 突变体
下载PDF
USH1C基因内含子新突变导致一耳聋家系的研究
4
作者 赵涛涛 马秀丽 +2 位作者 林垦 明澄 马静 《中国耳鼻咽喉头颈外科》 CSCD 2023年第5期300-304,共5页
目的 对一个耳聋家系,应用高通量测序技术、Minigene实验,对其听力损失病因及分子生物学致病原因进行探究。方法 首先采集先证者及家系成员的病史、绘制家系图,并进行听力学评估及耳部影像学检查。获取该家系2代3人外周血提取基因组DNA... 目的 对一个耳聋家系,应用高通量测序技术、Minigene实验,对其听力损失病因及分子生物学致病原因进行探究。方法 首先采集先证者及家系成员的病史、绘制家系图,并进行听力学评估及耳部影像学检查。获取该家系2代3人外周血提取基因组DNA,对患儿采用高通量测序方法对406个耳聋基因编码区的全部外显子及部分内含子和启动子进行检测,筛选疑似致病突变,针对变异位点对家系成员进行Sanger测序验证,应用Minigene实验进行验证。结果 患儿表现为双侧极重度聋,高通量测序结果为USH1C纯合突变c.388-1G>A,导致氨基酸发生剪接突变,根据美国医学遗传学与基因组学学会(ACMG)指南,该变异初步判定为疑似致病性变异;Sanger测序验证其父母均为该位点的杂合携带者。Minigene实验表明该位点突变会导致m RNA异常剪接。结论 本家系中发现的USH1C基因内含子新突变为致病性突变,该突变导致先证者耳聋。 展开更多
关键词 USHER综合征 耳聋 内含子 突变 USH1C基因 微小基因
下载PDF
A novel pathogenic splicing mutation of RPGR in a Chinese family with X-linked retinitis pigmentosa verified by minigene splicing assay
5
作者 Hui-Qin Wang Pei-Kuan Cong +2 位作者 Tian He Xiao-Feng Yu Ya-Nan Huo 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2023年第10期1595-1600,共6页
AIM:To report a novel splicing mutation in the RPGR gene(encoding retinitis pigmentosa GTPase regulator)in a three-generation Chinese family with X-linked retinitis pigmentosa(XLRP).METHODS:Comprehensive ophthalmic ex... AIM:To report a novel splicing mutation in the RPGR gene(encoding retinitis pigmentosa GTPase regulator)in a three-generation Chinese family with X-linked retinitis pigmentosa(XLRP).METHODS:Comprehensive ophthalmic examinations including best corrected visual acuity,fundus photography,vision field,and pattern-visual evoked potential were performed to identify the disease phenotype of a six-yearold boy from the family(proband).Genomic DNA was extracted from peripheral blood of five available members of the pedigree.Whole-exome sequencing(WES),Sanger sequencing,and pSPL3-based exon trapping were used to investigate the aberrant splicing of RPGR.Human Splice Finder v3.1 and NNSPLICE v0.9 were used for in silico prediction of splice site variants.RESULTS:The proband was diagnosed as having retinitis pigmentosa(RP).He had severe symptoms with early onset.A novel splicing mutation,c.619+1G>C in RPGR was identified in the proband by WES and in four family members by Sanger sequencing.Minigene splicing assays verified that c.619+1G>C in RPGR would result in the formation of a damaging alternative transcript in which the last 91 bp of exon 6 were skipped,leading to the subsequent deletion of 623 correct amino acids(c.529_619del p.Val177Glnfs*16).CONCLUSION:We identify a novel splice donor site mutation causing aberrant splicing of RPGR.Our findings add to the catalog of pathological mutations of RPGR and further emphasize the functional importance of RPGR in RP pathogenesis and its complex clinical phenotypes. 展开更多
关键词 retinitis pigmentosa X-linked inheritance RPGR splicing mutation pSPL3 minigene assay
下载PDF
NIPBL基因剪接变异致德朗热综合征1型胎儿的产前诊断及遗传学分析
6
作者 梁磊 王海欣 +1 位作者 蔡泽宇 赵建荣 《中华医学遗传学杂志》 CAS CSCD 2022年第10期1107-1110,共4页
目的分析一例德朗热综合征1型胎儿的遗传学病因。方法收集胎儿及其父母的临床资料,采集羊水及父母的外周血样,提取基因组DNA,通过全基因组低深度重测序、全外显子组测序(whole exome sequencing,WES)及Sanger测序筛查NIPBL基因的变异位... 目的分析一例德朗热综合征1型胎儿的遗传学病因。方法收集胎儿及其父母的临床资料,采集羊水及父母的外周血样,提取基因组DNA,通过全基因组低深度重测序、全外显子组测序(whole exome sequencing,WES)及Sanger测序筛查NIPBL基因的变异位点,参考美国医学遗传学与基因组学学会指南判断变异的致病性,利用minigene技术分析变异对mRNA的影响。结果测序结果提示胎儿NIPBL基因的内含子上存在c.5808+5G>A杂合变异,预测可能影响mRNA剪接,胎儿父母未检测到相同的变异。上述变异在ExAC、1000G、dbSNP等数据库中均未见收录,综合分析判断其为有害变异。minigene实验结果证实该变异会影响mRNA剪接,导致第31外显子的跳跃。结论确诊了一例德朗热综合征1型胎儿。minigene实验可以在体外验证WES检测所发现的剪接变异,可为判断这类变异的致病性提供更多的证据。 展开更多
关键词 德朗热综合征1型 NIPBL基因 全外显子组测序 minigene
原文传递
Establishment and application of minigene models for studying pre-mRNA alternative splicing 被引量:1
7
作者 LI Jing CHEN Xianhua +3 位作者 LIN Wanmin LI Lishu HAN Yu XU Ping 《Science China(Life Sciences)》 SCIE CAS 2004年第3期211-218,共8页
The objective of the present study is to establish a minigene model for studying pre-mRNA alternative splicing. To prepare the minigene DNA constructs, with human or mouse genomic DNA as templates, GluR-B , FGF-2R and... The objective of the present study is to establish a minigene model for studying pre-mRNA alternative splicing. To prepare the minigene DNA constructs, with human or mouse genomic DNA as templates, GluR-B , FGF-2R and Zis 搈inigene?fragments were amplified us-ing PCR and cloned to the eukaryotic expression vectors. The three constructed minigenes and the expression vectors of Tra2b1 and Zis2 were co-transfected in Hela cells. RT-PCR analysis was performed to semi-quantitatively determine the spliced products from the minigenes. The results demonstrated that the constructed minigenes are useful in studying the pre-mRNA al-ternative splicing in cultured cells. With the established Zis minigene, we for the first time found that Zis2 isoform regulates the alternative splicing of Zis minigene. 展开更多
关键词 minigene GluR-B FGF-2R ZIS Tra2β pre-mRNA splicing.
原文传递
Rescue of the albino phenotype by introducing a functional tyrosinase minigene into Kunming albino mice 被引量:2
8
作者 Dong Xiao Ying Yue +8 位作者 Xin-Yan Deng Bing Huang Zhong-Min Guo Yun Ma Yi-Li Lin Xun Hong Huan Tang Kang Xu Xi-Gu Chen 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第2期244-249,共6页
AIM: To use the tyrosinase minigene as a visual marker to perform microinjection training and improve the techniques related with transgene to greatly elevate the effidency of gene transfer. METHODS: A mouse tyrosin... AIM: To use the tyrosinase minigene as a visual marker to perform microinjection training and improve the techniques related with transgene to greatly elevate the effidency of gene transfer. METHODS: A mouse tyrosinase minigene, i.e., TyBS, in which the 2.25-kb authentic genomic 5' non-coding flanking sequence of mouse tyrosinase was fused to a mouse tyrosinase cDNA, was introduced into the fertilized eggs of outbred Kunming albino mice. RESULTS: Of the 11 animals that developed from the injected eggs, two mice (P1 and #8) exhibited pigmented hair (P1) and eyes (P1 and #8), as confirmed by PCR analysis for the tyrosinase minigene integrated into the genome. When founder P1 was bred to Kunming male mouse, six progeny out of 11 offspring inherited the transgene and the pigmented-eye phenotype. CONCLUSION: Taken together, these results suggest that this minigene encodes the active tyrosinase protein and that its 5' flanking region contains the sequences regulating the expression of mouse tyrosinase gene as expected. We have rescued the albino phenotype by introduction and expression of a functional tyrosinase minigene in the Kunming albino mouse and the transgene can be passed to subsequent generation. These findings also indicate that TyBS can be a useful visual marker gene in the co-transgenic experiments. 展开更多
关键词 minigene Transgenic mice MELANIZATION Phenotypic rescue
下载PDF
遗传性乳光牙本质家系致病基因突变的鉴定 被引量:3
9
作者 刘彦山 黄颖之 +3 位作者 高劲松 李闪 赵秀丽 张学 《中华医学遗传学杂志》 CAS CSCD 北大核心 2016年第1期34-37,共4页
目的对一个遗传性乳光牙本质(dentinogenesis imperfecta shieldstype Ⅱ ,DGI-Ⅱ)家系进行DSPP基因的突变分析。方法采集家系成员外周血或胎儿绒毛组织,用酚氯仿法提取基因组DNA。应用聚合酶链反应(polymerasechain reaction,PCR... 目的对一个遗传性乳光牙本质(dentinogenesis imperfecta shieldstype Ⅱ ,DGI-Ⅱ)家系进行DSPP基因的突变分析。方法采集家系成员外周血或胎儿绒毛组织,用酚氯仿法提取基因组DNA。应用聚合酶链反应(polymerasechain reaction,PCR)-Sanger测序方法鉴定先证者DSPP基因第2~5外显子及外显子/内含子衔接区序列,并进行突变分析;针对突变位点设计错配引物引入AluI酶切位点,通过限制性酶切和琼脂糖凝胶电泳方法在该家系正常人及60名无关正常个体中进行致病突变验证;构建含微型DSPP基因的pcDNA3.1基因表达载体,在体外培养细胞中验证突变致病性。结果该家系3例患者和一名胎儿均携带DSPP基因内C.52—1G〉A的杂合突变,突变造成该基因第3外显子5’端剪接点变异;60名对照者和家系正常个体均未携带该突变;微小基因(Minigene)体外表达显示e.52—1G〉A导致DSPP基因转录产物第3外显子的跳跃剪接。结论本研究在一个DGI-Ⅱ家系中发现了DSPP基因内一个新的致病剪接突变(c.52—1G〉A),并在此基础上为先证者提供了产前基因诊断。 展开更多
关键词 乳光牙 DSPP基因 剪接点突变 微小基因
原文传递
Effects of splice sites on the intron retention in histamine H_3 receptors from rats and mice
10
作者 Wenyong Ding Lin Lin +3 位作者 Feng Ren Hanfa Zou Ziyuan Duan Jianwu Dai 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2009年第8期475-482,共8页
In the alternative splicing, intron retention, of histamine H3 receptors in rats and mice, the short transcript isoforms that are excised alternatively spliced introns are easily detected in a very low level in rats a... In the alternative splicing, intron retention, of histamine H3 receptors in rats and mice, the short transcript isoforms that are excised alternatively spliced introns are easily detected in a very low level in rats and are undetectable in mice using the regular PCR protocol. The retained introns have common 5' splice site and different 3' splice sites. The detailed mechanism for the special alternative splicing remains largely unclear. In this study, we developed a minigene splicing system to recapitulate natural alternative splicing of the receptors and investigated the effects of 5' and 3' splice sites on intron retention in HeLa cells. Mutating weak 5' and 3' splice sites of the alternatively spliced introns toward the canonical consensus sequences promoted the splicing of the corresponding introns in rat and mouse minigenes. The effect of splice site strength was context-dependent and much more sigiaificant for the 3' splice site of the longer alternative intron than for the 3' splice site of the shorter alternative intron and the common 5' splice sites; it was also more significant in the rat minigene than in the mouse minigene. Mutating the 3' splice site of the longer alternative intron resulted in almost complete splicing of the intron and made the corresponding isoform to become the nearly exclusive transcript in the rat minigene. 展开更多
关键词 histamine H3 receptor (H3R) altemative splicing intron retention splice site minigene
原文传递
Minigene Analysis of the c.743 + 40A >G Intronic Variant in the <i>CFTR</i>Gene
11
作者 Ayman El-Seedy Raed Farhat +2 位作者 Marie-Claude Pasquet Alain Kitzis Véronique Ladeveze 《Health》 2014年第12期1352-1360,共9页
Background: Since the identification of the cystic fibrosis transmembrane regulator (CFTR) gene in 1989, many polymorphisms have been identified in cystic fibrosis (CF) or CFTR-related disorders (CFTR-RDs) patients an... Background: Since the identification of the cystic fibrosis transmembrane regulator (CFTR) gene in 1989, many polymorphisms have been identified in cystic fibrosis (CF) or CFTR-related disorders (CFTR-RDs) patients and still remain to be characterized at the molecular level. These polymorphisms are difficult to classify as pathogenic or non-disease causing because the polymorphisms are either located in the coding region, but are synonymous, or are found in the intronic regions. Here we investigated the potential impact of the c.743 + 40A > G polymorphism within CFTR intron 6 on the alternative splicing. Indeed, this variant has been observed frequently in our examined patients. Moreover, a family carrying this variant exhibited CFTR-RD phenotype. Methods: By denaturing high pressure liquid phase chromatography (DHPLC) and sequencing, thirty of 293 subjects French origin carried the c.743 + 40A > G variant. Of these, 16 patients were affected by CF or CFTR-RD. Wild-type sequences and mutant CFTR intron 6 and its boundaries were inserted into the pTBNdeI hybride minigene and expressed in three different cell lines. After RT-PCR analysis of mRNA using specific primers, sequences of the minigene transcripts were obtained. Results: No aberrant splicing was detected with minigene carrying c.743 + 40A > G variant in all transfected cell lines. However, an alternative splicing in the positive control was detected with a minigene carrying the c.1392G > T + 1G > T mutation: 5 nucleotides were deleted from mRNA sequences, indicating that used cell lines are appropriate for studying the splicing. Conclusion: Transient transfections of a minigene containing the c.743 + 40A > G polymorphism showed no splicing errors, and thus this intronic alteration was finally classified as non-pathogenic. As it is always associated with c.2562T > G and c.4389G > A, or TG12-7T poly-morphisms, further experiments are needed to determine the role of these complex alleles in disease pathogenesis. 展开更多
关键词 CYSTIC Fibrosis Polymorphism Complex ALLELE Hybrid minigene Splicing
下载PDF
CEA迷你基因原核表达及其诱导小鼠特异性淋巴细胞增殖的研究 被引量:2
12
作者 李丹 方艳秋 +3 位作者 谭岩 刘力华 段秀梅 许淑芬 《免疫学杂志》 CAS CSCD 北大核心 2008年第4期400-403,共4页
目的在原核细胞中表达人癌胚抗原(CEA)的迷你基因短肽,纯化及鉴定目的蛋白,并检测其在小鼠体内的抗原性。方法利用PCR技术从人基因组中得到一段来源于CEA的DNA序列,其中包含两个编码分别能被HLA—DR4/9、HLA—DR53以及HLA-DR4/7... 目的在原核细胞中表达人癌胚抗原(CEA)的迷你基因短肽,纯化及鉴定目的蛋白,并检测其在小鼠体内的抗原性。方法利用PCR技术从人基因组中得到一段来源于CEA的DNA序列,其中包含两个编码分别能被HLA—DR4/9、HLA—DR53以及HLA-DR4/7/9型别的人群所识别辅助性T细胞(HTL)表位的迷你基因,构建重组表达质粒pQE30-CEA625-667,在大肠杆菌M15中诱导表达。Westren Blot杂交鉴定、镍凝胶亲和层析法纯化目的蛋白。3H—TdR掺入法检测目的短肽诱导的小鼠淋巴细胞增殖反应。结果CEA625-667短肽在大肠杆菌M15中以包涵体形式表达。Western—blot结果显示,在相对分子质量约6700处有表达产物与6×hismAb特异性结合带。镍柱纯化后可得到纯化的目的蛋白.3H-TdR掺入实验所得不同浓度的CEA625-667与小鼠脾细胞共孵育7~9d后的刺激指数相继达到对照组的10倍以上。结论成功诱导了CEA625-667短肽的原核表达,通过镍凝胶亲和层析法获得纯度较高的CEA625-667短肽,并证明在一定浓度下目的短肽可于体外诱导小鼠的特异性淋巴细胞增殖。为CEA625-667迷你基因作为表位疫苗在抗肿瘤方面的进一步研究提供条件。 展开更多
关键词 癌胚抗原 迷你基因 表位 大肠杆菌 特异性淋巴细胞增殖
下载PDF
NT4-TAT-6×His-VHLβ结构域肾癌抑制融合肽cDNA克隆的构建 被引量:1
13
作者 陈杰 刘庆勇 +5 位作者 阮喜云 张士宝 张建军 李宗武 杨广笑 王全颖 《山东大学学报(医学版)》 CAS 北大核心 2009年第7期32-36,共5页
目的构建VHL蛋白(von Hippel-Lindau protein,pVHL)β结构域肾癌抑制融合肽cDNA,并将其应用于肾癌的微基因治疗。方法分别设计合成pVHLβ结构域104-123短肽cDNA的正向和反向引物以及编码TAT-6×His cD-NA的正、反向引物,使用互为引... 目的构建VHL蛋白(von Hippel-Lindau protein,pVHL)β结构域肾癌抑制融合肽cDNA,并将其应用于肾癌的微基因治疗。方法分别设计合成pVHLβ结构域104-123短肽cDNA的正向和反向引物以及编码TAT-6×His cD-NA的正、反向引物,使用互为引物模板PCR方法,扩增获得具有NaeI/Eco72I酶识别位点的TAT-6×His cDNA片段和具有Eco72I/BamH I酶识别位点的VHLβ抑制肽cDNA片段,将两个片段分别克隆到pGEM-T easy中,使用双脱氧终止法测序,通过DNASIS软件分析同数据库资料一致性和编码的氨基酸序列。用NaeI和BamH I双酶切获取的TAT-6×His-VHLβcDNA片段插入到具有NT4信号肽的pBV220载体中,构建了pBV220-NT4-TAT-6×His-VHLβ质粒。结果经DNA测序证实,获得了编码TAT-6×His cDNA片段和编码VHLβ抑制肽的cDNA片段,分析证实核酸序列和推导的氨基酸同数据库资料一致。重组质粒pBV220-NT4-TAT-6×His-VHLβ酶切图谱证实已将NT4-TAT-6×His-VHLβ融合肽cDNA克隆到pBV220原核表达载体中。结论成功扩增了编码TAT膜渗透肽和6×His标签肽以及VHL抑癌基因β结构域肾癌抑制肽的cDNA片段,构建了具有NT4信号肽的TAT-6×His-VHLβ融合肽cDNA。 展开更多
关键词 VHLβ结构域肾癌抑制肽 融合肽 微基因 肾肿瘤
原文传递
Novel mutation c.1210-3C>G in cis with a poly-T tract of 5T affects CFTR mRNA splicing in a Chinese patient with cystic fibrosis 被引量:1
14
作者 Xinyue Zhao Keqiang Liu +8 位作者 Wenshuai Xu Meng Xiao Qianli Zhang Jiaxing Song Keqi Chen Yaping Liu Xinlun Tian Kai-Feng Xu Xue Zhang 《Frontiers of Medicine》 SCIE CSCD 2022年第1期150-155,共6页
Cystic fibrosis(CF)is a rare autosomal recessive disease with only one pathogenic gene cystic fibrosis transmembrane conductance regulator(CFTR).To identify the potential pathogenic mutations in a Chinese patient with... Cystic fibrosis(CF)is a rare autosomal recessive disease with only one pathogenic gene cystic fibrosis transmembrane conductance regulator(CFTR).To identify the potential pathogenic mutations in a Chinese patient with CF,we conducted Sanger sequencing on the genomic DNA of the patient and his parents and detected all 27 coding exons of CFTR and their flanking intronic regions.The patient is a compound heterozygote of c.2909G>A,p.Gly970Asp in exon 18 and c.1210-3C>G in cis with a poly-T of 5T(T5)sequence,3 bp upstream in intron 9.The splicing effect of c.1210-3C>G was verified via minigene assay in vitro,indicating that wild-type plasmid containing c.1210-3C together with T7 sequence produced a normal transcript and partial exon 10-skipping-transcript,whereas mutant plasmid containing c.1210-3G in cis with T5 sequence caused almost all mRNA to skip exon 10.Overall,c.1210-3C>G,the newly identified pathogenic mutation in our patient,in combination with T5 sequence in cis,affects the CFTR gene splicing and produces nearly no normal transcript in vitro.Moreover,this patient carries a p.Gly970Asp mutation,thus confirming the high-frequency of this mutation in Chinese patients with CF. 展开更多
关键词 cystic fibrosis CFTR splicing mutation minigene
原文传递
CEA迷你基因串联体疫苗免疫小鼠脾细胞对CEA阳性肿瘤细胞的杀伤作用及疫苗的安全性评价 被引量:1
15
作者 方艳秋 魏海峰 +5 位作者 李丹 米旭光 芦小单 李首庆 刘磊 谭岩 《中国免疫学杂志》 CAS CSCD 北大核心 2017年第2期217-219,225,共4页
目的:观察CEA迷你基因串联体疫苗pcD NA-triC EA625-667免疫小鼠脾细胞对肿瘤细胞特异性杀伤作用并对疫苗免疫小鼠后的安全性进行评估。方法:BALB/c小鼠随机分为空白载体组(pcD NA3.0)、单倍体疫苗实验组(pcD NACEA625-667)、串联体疫... 目的:观察CEA迷你基因串联体疫苗pcD NA-triC EA625-667免疫小鼠脾细胞对肿瘤细胞特异性杀伤作用并对疫苗免疫小鼠后的安全性进行评估。方法:BALB/c小鼠随机分为空白载体组(pcD NA3.0)、单倍体疫苗实验组(pcD NACEA625-667)、串联体疫苗实验组(pcD NA-triC EA625-667),肌肉注射法免疫动物,每隔10 d免疫1次,共免疫4次,记录免疫小鼠的体重变化、存活情况以及检测血清ALT、肌酐水平。以疫苗免疫小鼠的脾细胞为效应细胞,以LDH释放法检测其对CEA阳性的小鼠肝癌细胞株(H22-CEA+)、胃癌细胞株(MFC-CEA+)、结肠癌细胞株(CT26-CEA+)以及CEA阴性小鼠肝癌细胞株(H22-CEA-)的特异性CTL的杀伤活性。结果:两种疫苗对CEA阳性的肝癌、胃癌及结肠癌细胞均具有较强的杀伤活性,与PcDNA3.0空载体组相比,差异有统计学意义(P<0.01)。而对CEA阴性肿瘤细胞(H22-CEA-)则几乎无影响。迷你串联体基因疫苗pcD NA-triC EA+625-667对肝癌细胞H22-CEA及胃癌细胞MFC-CEA+的杀伤活性强于单倍体基因疫苗pcD NA-CEA625-667(P<0.05)。疫苗免疫对小鼠的存活状态、体重变化及肝肾功能指标均无影响。结论:CEA迷你基因疫苗安全有效,能够诱导肿瘤特异性CTL产生,且三倍体串联体疫苗免疫效果优于单倍体疫苗。 展开更多
关键词 癌胚抗原 迷你基因 基因疫苗 体外实验 抗肿瘤
下载PDF
典型结节性硬化症1例临床表型及基因变异分析
16
作者 刘林莉 严高武 +4 位作者 邓玲俐 鲁青莲 刘婷婷 欧阳飞 于春水 《中华皮肤科杂志》 CAS CSCD 北大核心 2022年第8期713-716,共4页
目的收集1例典型结节性硬化症患者的临床资料并检测其致病基因变异。方法收集患者临床资料,应用二代测序法对患者进行致病基因筛查,采用Sanger测序法验证,构建迷你基因质粒转染至人肾上皮细胞系293T细胞,提取RNA进行转录分析。结果患者... 目的收集1例典型结节性硬化症患者的临床资料并检测其致病基因变异。方法收集患者临床资料,应用二代测序法对患者进行致病基因筛查,采用Sanger测序法验证,构建迷你基因质粒转染至人肾上皮细胞系293T细胞,提取RNA进行转录分析。结果患者临床表型包括反复癫痫发作,伴面部血管纤维瘤、甲周纤维瘤、肺淋巴管肌瘤病、肾血管平滑肌脂肪瘤及多发性骨质硬化。二代测序提示患者TSC2基因存在可疑致病变异,经Sanger测序验证,患者TSC2基因第4号外显子存在c.336_336+15delGGTAAGGCCCAGGGCG杂合突变,其父母及100名无关健康对照未检测出该位点变异。该突变位点既往未见报道。迷你基因实验显示,患者TSC2基因mRNA序列发生改变,原4号外显子剪切位点丢失,插入74 bp内含子序列,使剪切位置后移90 bp(r.336delins336+16_336+90)。结论TSC2基因第4号外显子c.336_336+15delGGTAAGGCCCAGGGCG杂合变异可导致异常剪切,可能是该结节性硬化症患者病因。 展开更多
关键词 结节性硬化症 DNA突变分析 TSC2基因 迷你基因
原文传递
Novel hydroxymethylbilane synthase gene mutation identified and confirmed in a woman with acute intermittent porphyria:A case report
17
作者 Yu-Qing Zhou Xiao-Qing Wang +3 位作者 Jun Jiang Shu-Ling Huang Zhuo-Jin Dai Qiao-Qiong Kong 《World Journal of Clinical Cases》 SCIE 2022年第33期12319-12327,共9页
BACKGROUND Acute intermittent porphyria(AIP)is a rare autosomal dominant porphyrin metabolic disease caused by a mutation in the hydroxymethylbilane synthase(HMBS)gene.This study aimed to explore the clinical manifest... BACKGROUND Acute intermittent porphyria(AIP)is a rare autosomal dominant porphyrin metabolic disease caused by a mutation in the hydroxymethylbilane synthase(HMBS)gene.This study aimed to explore the clinical manifestations of a patient with AIP,to identify a novel HMBS gene mutation in the proband and some of her family members,and to confirm the pathogenicity of the variant.CASE SUMMARY A 22-year-old Chinese woman developed severe abdominal pain,lumbago,sinus tachycardia,epileptic seizure,hypertension,and weakness in lower limbs in March,2018.Biochemical examinations indicated hypohepatia and hyponatremia.Her last menstrual period was 45 d prior to admission,and she was unaware of the pregnancy,which was confirmed by a pregnancy test after admission.Sunlight exposure of her urine sample for 1 h turned it from yellow to wine red.Urinary porphyrin test result was positive.Based on these clinical manifestations,AIP was diagnosed.After increasing her daily glucose intake(250–300 g/d),abdominal pain was partially relieved.Three days after hospitalization,spontaneous vaginal bleeding occurred,which was confirmed as spontaneous abortion;thereafter,her clinical symptoms completely resolved.Genetic testing revealed a novel heterozygous splicing variant of the HMBS gene in exon 10(c.648_651+1delCCAGG)in the proband and four other family members.The pathogenicity of the variant was verified through bioinformatic methods and a minigene assay.CONCLUSION We identified a novel HMBS gene mutation in a Chinese patient with AIP and confirmed its pathogenicity. 展开更多
关键词 Acute intermittent porphyria Hydroxymethylbilane synthase gene Novel mutation minigene assay Bioinformatics analysis Case report
下载PDF
一个中国Alport综合征家系中剪接突变及致病性分析 被引量:1
18
作者 吕幸 吴维青 +6 位作者 崔英霞 陈芳芳 孙宁 姚新月 夏正坤 刘志红 李晓军 《医学研究生学报》 CAS 北大核心 2019年第6期619-623,共5页
目的对一个中国Alport综合征家系进行基因变异检测,并对发现的基因变异进行致病性分析。方法采用目标序列捕获芯片联合高通量测序技术对先证者进行基因变异检测,应用Sanger测序技术对可疑位点进行家系验证,通过体外 Mini 基因实验分析... 目的对一个中国Alport综合征家系进行基因变异检测,并对发现的基因变异进行致病性分析。方法采用目标序列捕获芯片联合高通量测序技术对先证者进行基因变异检测,应用Sanger测序技术对可疑位点进行家系验证,通过体外 Mini 基因实验分析基因变异对 pre-mRNA 剪接过程的影响。结果先证者 COL4A5 基因 32 号外显子发现一杂合变异c.2767G>T(p.Gly923Cys),为新发现的变异。Sanger 测序验证此变异在家系中与疾病呈现共分离。体外 Minigene 实验表明, c.2767G>T 突变可造成 COL4A5基因 32号外显子缺失。结论通过目标序列捕获芯片联合高通量测序技术发现一个新的COL4A5基因突变,丰富了Alport综合征突变谱;通过体外Minigene实验证实c.2767G>T突变为一剪接突变,促进了对Alport综合征分子发病机制的理解。 展开更多
关键词 ALPORT综合征 COL4A5基因 剪接突变 高通量测序 Mini基因
下载PDF
BDNF对H_2O_2诱导人成纤维细胞凋亡的实验研究 被引量:1
19
作者 陈建业 王晓明 +5 位作者 唐中 陈瑾歆 刘戟 王若菡 刘智敏 陈俊杰 《川北医学院学报》 CAS 2004年第2期2-5,共4页
目的研究脑源性神经营养因子 (BDNF)对H2 0 2 诱导人成纤维细胞 (hFB)凋亡的作用。方法 将含人Ⅰ型胶原a1链(COLIAl)基因启动子和增强子元件并在其 3′端接BDNFcDNA的微基因pSVCEPBFCAT ,经脂质体介导转染hFB并驱动BDNF异位表达 ,采用... 目的研究脑源性神经营养因子 (BDNF)对H2 0 2 诱导人成纤维细胞 (hFB)凋亡的作用。方法 将含人Ⅰ型胶原a1链(COLIAl)基因启动子和增强子元件并在其 3′端接BDNFcDNA的微基因pSVCEPBFCAT ,经脂质体介导转染hFB并驱动BDNF异位表达 ,采用四唑盐 (MTT)显色法检测细胞增殖 ,吖啶橙荧光染色显微镜观察细胞形态的改变 ,琼脂糖凝胶电泳检测染色质DNA断裂。结果 经 2 0 0 μmol/LH2 O2 作用 2 4h后 ,pSVCEPBFCAT转染组和对照组包括未转染hFB、空载体pSVCEPCAT转染hFB的细胞生长抑制率分别为 35 %和≥ 84 % ,p <0 .0 0 1;对照组hFB普遍可见凋亡细胞特有的形态学及生物化学改变 ,如胞浆和核固缩、染色质断裂、DNA电泳呈阶梯状条带 ,而pSVCEPBFCAT转染hFB未发现上述凋亡特征。结论 BDNF促进hFB增殖和拮抗H2 O2 诱导凋亡 ,明显抑制H2 O2 对hFB的细胞毒性。 展开更多
关键词 BDNF H2O2 诱导 成纤维细胞 细胞凋亡 实验研究
下载PDF
ENDOGENOUS EXPRESSION AND HLA STABILIZATION ASSAY OF PLASMODIUM FALCIPARUM CTL EPITOPE MINIGENE IN HUMAN HLA- A2.1 AND HLA- B51 CELLS
20
作者 唐玉阳 王恒 《Chinese Medical Sciences Journal》 CAS CSCD 2001年第1期29-34,共6页
To evaluate the Plasmodium falciparum CTL epitope vaccines in HLA class I allele specific human cell lines that have high frequency among Chinese population. Methods. Synthesized oligonucleotides encoding for P.f. CTL... To evaluate the Plasmodium falciparum CTL epitope vaccines in HLA class I allele specific human cell lines that have high frequency among Chinese population. Methods. Synthesized oligonucleotides encoding for P.f. CTL epitope genes, constructed eukaryotic expression plasmids, transfected the minigenes into HLA class I allele specific human cell lines and identified endogenous expressing of the minigenes by RT- PCR and HLA stabilization assay. Results. Two mini- genes encoding Plasmodium falciparum CTL epitopes were designed and cloned, respectively, into an eukaryotic expressing vector to form TR26 which was restricted to HLA- B51, SH6 which was restricted to HLA- A2.1, and TS, which had the two aforementioned mini- genes fused in tandem. All of these CTL epitope genes were transfected and endogenously expressed in respective cell lines containing appropriate HLA molecules. The obviously increased expressions of HLA class I molecules were detected in the transfected cell lines. It was demonstrated that the two discrete Plasmodium falciparum epitope genes were effectively processed and presented, and the close proximity of the two epitope genes in one chain as in mini- gene TS did not interfere with the processing and presenting of each epitope gene in corresponding cell line. Conclusion. A successful expression and presentation of multiple CTL epitope mini- gene in MHC class I allele specific human cell lines were demonstrated by an in vitro assay, which could be corresponding to the vaccination of CTL vaccines in people with different MHC I molecules. This work also suggested the possibility of constructing a multiple CTL epitope plasmodium falciparum DNA vaccine that could cover most of Chinese population. 展开更多
关键词 endogenous expressing peptide epitope minigene CTL HLA stabilization assay
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部